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Sclerotherapy involves injecting detergent sclerosants, chemical irritants, or hyperosmolar agents into the lymphatic malformations to destroy the aberrant vessels. Injectable corticosteroids, tetracycline, 50% dextrose solution, and hyperosmolar saline have all been used in case reports and preliminary trials. [5, 6] For sclerotherapy, intralesional injection of 1% sodium tetradecyl sulfate is used with a very good result. Sclerotherapy using sodium tetradecyl sulfate can be considered a successful minimally invasive treatment option for LC. Depending on the study, recurrence rates vary from 58% to 100%. Cryotherapy utilizes very low temperatures to cause immediate vasoconstriction followed by reactive vasodilation, in turn producing cellular necrosis and healing by secondary intention. Recently, imiquimod cream has been used successfully. Imiquimod induces cellular production of endogenous interferons and interleukins. [7] Efficacy in these patients is likely related to the ability to inhibit vessel formation and induce endothelial cell apoptosis.
Surgical excision is regarded as the most definitive treatment, giving the highest chance of cure with a recurrence rate of 17% to 23%. [8] By completely excising the subcutaneous cisterns and removing the source of the vesicles, it is possible to eliminate the cutaneous manifestations. Whereas surgical excision offers definitive treatment, it also involves significant risks including scarring, keloid formation, hematoma, wound infection, and nerve injury. Surgery gives the lowest rates of recurrence, but has the highest risk of complications. [9] However, this may not be feasible in some situations when the involvement is extensive. Recurrence is the rule with other forms of destructive therapy. To conclude, clinicians should discuss goals of treatments with patients when designing a therapeutic plan.
Letters to the Editor

An interesting observation of polymorphous light eruption occurring on hypopigmented scars
Sir, Polymorphous light eruption (PMLE), as the name indicates can present in myriad morphological forms; but the occurrence of these lesions on scars is practically unknown. Herein, we report an interesting observation of PMLE preferentially involving the sites of hypopigmented scars.
A 28-year-old male reported to the dermatology outpatient department with pruritic papular eruptions on the outer aspect of forearms. The lesions were confined to the sites of hypopigmented scars on the forearms that were the sequelae of burn injury that he sustained before 3 months. The patient stated that these lesions developed within an hour of exposure to sunlight. He was treated with topical steroids and the lesions Figure 6 ] The diagnosis of PMLE was established on the basis of clinical, histopathological and photoprovocation test findings. As there was a predilection for the PMLE lesions to involve the hypopigmented scars, we would like to propose a new term for this variant of PMLE, the "scar PMLE".
Polymorphous light eruption has been reported to present in a variety of morphological forms; papular, papulovesicular, vesiculobullous, insect bite-like, erythema multiforme-like and eczematous. Papular type is the most common followed by the papulovesicular type. [1] In this case, PMLE lesions occurring in hypopigmented scars is a unique phenomenon not described previously. Possible pathomechanisms underlying PMLE lesions that preferentially affect scar sites have not been considered before. Increased density and activity in scar sites of Langerhans cells that are also key to immunological events leading to PMLE might be the reason. [2, 3] Thus, the phenomenon can be explained as Wolff's isotopic phenomenon because of increase in the number and activity of Langerhans cells in the resolved completely. Few days later, the patient presented again with grouped micropapular lesions on the extensor aspect of forearms involving the scars as well as areas of normal skin symmetrically. After the lesions had resolved, a photoprovocation test (the patient was asked to expose the scars that co-mediate type 4 hypersensitivity of PMLE. Paucity of melanin in the hypopigmented scars and the consequent focal reduction in photo-protection may also be contributory. Nonetheless, we need to probe deeper to fully understand the pathophysiology of this distinctive phenomenon -"scar PMLE".
Perforating granuloma annulare in a young male following application of the tattoo Sir, Perforating granuloma annulare (PGA) is a very rare subtype of granuloma annulare (GA), reported on the extremities of children and young adults. [1] [2] [3] This variant has a chronic course, and isolated cases have been reported in association with diabetes mellitus, tuberculosis, rheumatoid arthritis, HIV/ AIDS and herpes zoster infection. [3] [4] [5] It is characterized by a well-demarcated, annular lesion consisting of papules of 1-5 mm (most are umbilicated), with perforation in their centres. Pustular lesions and scars may be found. Lesions are usually located on the extremities but may also appear in other regions of the body. [6] A granulomatous reaction pattern resembling PGA within the confines of a tattoo, is a very rare finding, and only two such cases have been reported in English literature. [7, 8] A 24-year-old male developed an asymptomatic annular erythematous plaque on dorsum of his right hand 2-3 months after tattoo application. There were no systemic complaints. On closer examination, tiny papular lesions were seen all over the site of tattoo application, many of them having central plugs. There was a gradual increase in induration and thickness of the plaque,
